Gene Therapy for Prostate Cancer

Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic

(2010) C. M. Thirukkumaran et al.   CANCER RESEARCH

Tumour Targeting with Systemically Administered Bacteria

(2010) David Morrissey et al.   CURRENT GENE THERAPY

This manuscript (Mengesha A, Wei JZ, Zhou S-F, Wei MQ. Clostridial spores to treat solid tumours - potential for a new therapeutic modality. Cur Gene Ther 2010; 10 (1): 15-26.) is withdrawn at the request of the senior author, who apologized for any inconvenience.

(2010) Bentham Science Publisher Bentham Science Publisher   CURRENT GENE THERAPY

Engineered E. coli as Vehicles for Targeted Therapeutics

(2010) Caitlin Buttaro et al.   CURRENT GENE THERAPY

Salmonella as Live Trojan Horse for Vaccine Development and Cancer Gene Therapy

(2010) Maria Moreno et al.   CURRENT GENE THERAPY

Listeria monocytogenes as a Vector for Anti-Cancer Therapies

(2010) Mark Tangney et al.   CURRENT GENE THERAPY

DNA vaccines against cancer come of age

(2010) Freda K Stevenson et al.   CURRENT OPINION IN IMMUNOLOGY

Update on castrate-resistant prostate cancer: 2010

(2010) Kiran Lassi et al.   CURRENT OPINION IN ONCOLOGY

Current status of immunological therapies for prostate cancer

(2010) Emmanuel S Antonarakis et al.   CURRENT OPINION IN UROLOGY

A Novel Listeria monocytogenes-Based DNA Delivery System for Cancer Gene Therapy

(2010) Jan Peter van Pijkeren et al.   HUMAN GENE THERAPY

Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer

(2010) Chunyan Liu et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Sonoporation Mediated Immunogene Therapy of Solid Tumors

(2010) Garrett Casey et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer

(2009) Yi Lu   ADVANCED DRUG DELIVERY REVIEWS

DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer

(2009) Lindsey Low et al.   HUMAN GENE THERAPY

Prostate Stem Cell Antigen DNA Vaccination Breaks Tolerance to Self-antigen and Inhibits Prostate Cancer Growth

(2009) Sarfraz Ahmad et al.   MOLECULAR THERAPY

miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice

(2009) Cyrielle Clapé et al.   PLoS One

Tumoristatic effects of endostatin in prostate cancer is dependent on androgen receptor status

(2009) Tatyana Isayeva et al.   PROSTATE

Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells

(2008) W Song et al.   CANCER GENE THERAPY

Reovirus: Viral Therapy for Cancer ‘as Nature Intended’

(2008) C. Comins et al.   CLINICAL ONCOLOGY

Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy?

(2008) Sara Collins et al.   CURRENT GENE THERAPY

PTEN Knockout Prostate Cancer as a Model for Experimental Immunotherapy

(2008) Kazunori Haga et al.   JOURNAL OF UROLOGY

Cancer Immunotherapy — The Endgame Begins

(2008) Louis M. Weiner   NEW ENGLAND JOURNAL OF MEDICINE

Gene therapy in prostate cancer: past, present and future

(2007) Toshiro Shirakawa   Frontiers in Bioscience-Landmark